Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Nitric Oxide let's go!!!

View:

Post by indaknownewfie on May 18, 2021 6:37am

Nitric Oxide let's go!!!

FDA recognizes the critical unmet medical need for new, effective treatments for COVID-19, especially for severe forms of the disease. We are committed to working with sponsors of novel therapies to facilitate development and approval of new treatments.

229

Comment

Comment by mavericks2020 on May 18, 2021 7:38am

where is the news

Comment

Comment by mavericks2020 on May 18, 2021 8:51am

i find the news about FDA Claritas (TSXV:KLY) completes toxicology study with R-107 COVID-19 therapy Health Care, Market News TSXV:KLY $ Trevor Abestrevor.abes@themarketherald.ca12 March 2021 14:05 ...more

201

Comment

Comment by ETalien on May 18, 2021 9:06am

Can you add a link to this... thanks MAV!

Comment

Comment by mavericks2020 on May 18, 2021 9:18am

old news march12 https://themarketherald.ca/claritas-announces-completion-of-ind-enabling-rodent-toxicology-studies-with-r-107-2021-03-12/?utm_source=stockhouse.com&utm_medium=widget&utm_campaign=stockhouse.com%7Cwebpart_news%7Cnews_tab

119

Comment

Claritas Pharmaceuticals Inc